CS216246B2 - Method of making the substituted 2,3-alkylen-bis-+l oxy+pbenzamides - Google Patents

Method of making the substituted 2,3-alkylen-bis-+l oxy+pbenzamides Download PDF

Info

Publication number
CS216246B2
CS216246B2 CS775179A CS517977A CS216246B2 CS 216246 B2 CS216246 B2 CS 216246B2 CS 775179 A CS775179 A CS 775179A CS 517977 A CS517977 A CS 517977A CS 216246 B2 CS216246 B2 CS 216246B2
Authority
CS
Czechoslovakia
Prior art keywords
benzodioxane
alkyl
added
carboxylic acid
filtered
Prior art date
Application number
CS775179A
Other languages
Czech (cs)
English (en)
Inventor
Michel Thominet
Gerard Bulteau
Jacques Acher
Claude Collingnon
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7623835A external-priority patent/FR2360305A1/fr
Application filed by Ile De France filed Critical Ile De France
Publication of CS216246B2 publication Critical patent/CS216246B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/02—Seven-membered rings
    • C07D321/10—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CS775179A 1976-08-04 1977-08-04 Method of making the substituted 2,3-alkylen-bis-+l oxy+pbenzamides CS216246B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7623835A FR2360305A1 (fr) 1976-08-04 1976-08-04 Nouveaux 2,3-alkylene bis (oxy)benzamides substitues, leurs derives et leurs procedes de preparation

Publications (1)

Publication Number Publication Date
CS216246B2 true CS216246B2 (en) 1982-10-29

Family

ID=9176558

Family Applications (1)

Application Number Title Priority Date Filing Date
CS775179A CS216246B2 (en) 1976-08-04 1977-08-04 Method of making the substituted 2,3-alkylen-bis-+l oxy+pbenzamides

Country Status (37)

Country Link
JP (1) JPS57167914A (de)
AR (1) AR219709A1 (de)
AT (1) AT358034B (de)
AU (1) AU516033B2 (de)
BE (1) BE857350A (de)
BG (1) BG36496A3 (de)
CA (1) CA1114371A (de)
CH (1) CH629198A5 (de)
CS (1) CS216246B2 (de)
DD (1) DD133237A5 (de)
DE (1) DE2760414C2 (de)
DK (1) DK152366C (de)
EG (1) EG12716A (de)
ES (1) ES461175A1 (de)
FI (1) FI63938C (de)
GR (1) GR61351B (de)
HK (2) HK40382A (de)
HU (1) HU179064B (de)
IE (2) IE45647B1 (de)
IL (2) IL52644A0 (de)
IN (1) IN145473B (de)
LU (1) LU77897A1 (de)
MC (1) MC1154A1 (de)
MW (1) MW2077A1 (de)
NL (1) NL172063C (de)
NO (1) NO152133C (de)
NZ (1) NZ184816A (de)
OA (1) OA05728A (de)
PH (3) PH22114A (de)
PL (1) PL111071B1 (de)
PT (1) PT66865B (de)
RO (1) RO72963A (de)
SE (2) SE440776B (de)
SU (1) SU716523A3 (de)
YU (1) YU40005B (de)
ZA (1) ZA774701B (de)
ZM (1) ZM6077A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9027098D0 (en) * 1990-12-13 1991-02-06 Beecham Group Plc Pharmaceuticals
US10083697B2 (en) 2015-05-27 2018-09-25 Google Llc Local persisting of data for selectively offline capable voice action in a voice-enabled electronic device
JP6452575B2 (ja) * 2015-08-19 2019-01-16 株式会社トクヤマ ミルタザピンの製造方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1473829A (fr) * 1964-06-09 1967-03-24 Ile De France Nu-(tertiaire-aminoalkyl)-méthylène dioxybenzamides et leur préparation

Also Published As

Publication number Publication date
NL172063B (nl) 1983-02-01
DK152366B (da) 1988-02-22
ZA774701B (en) 1979-01-31
LU77897A1 (de) 1978-02-09
IN145473B (de) 1978-10-21
ATA569677A (de) 1980-01-15
YU40005B (en) 1985-06-30
PH22114A (en) 1988-06-01
SE7708849L (sv) 1978-02-05
AU2750777A (en) 1979-02-08
MC1154A1 (fr) 1978-04-17
OA05728A (fr) 1981-05-31
AT358034B (de) 1980-08-11
SE437027B (sv) 1985-02-04
GR61351B (en) 1978-10-26
DK346977A (da) 1978-02-05
DD133237A5 (de) 1978-12-20
PL200066A1 (pl) 1978-09-11
BE857350A (fr) 1978-02-01
HU179064B (en) 1982-08-28
NZ184816A (en) 1980-11-14
MW2077A1 (en) 1978-12-13
JPS57167914A (en) 1982-10-16
SE8206546L (sv) 1982-11-17
IE45647B1 (en) 1982-10-20
SU716523A3 (ru) 1980-02-15
AU516033B2 (en) 1981-05-14
EG12716A (en) 1979-09-30
ES461175A1 (es) 1978-12-01
IL66138A0 (en) 1982-09-30
PH17710A (en) 1984-11-19
AR219709A1 (es) 1980-09-15
HK40382A (en) 1982-09-24
DE2760414C2 (de) 1990-05-17
IL52644A0 (en) 1977-10-31
ZM6077A1 (en) 1979-05-21
PL111071B1 (en) 1980-08-30
NL172063C (nl) 1983-07-01
PT66865A (fr) 1977-08-01
HK40482A (en) 1982-09-24
SE440776B (sv) 1985-08-19
FI63938B (fi) 1983-05-31
CH629198A5 (fr) 1982-04-15
FI772362A (de) 1978-02-05
NO152133B (no) 1985-04-29
CA1114371A (en) 1981-12-15
SE8206546D0 (sv) 1982-11-17
SE453390B (sv) 1988-02-01
NO772739L (no) 1978-02-07
IE802409L (en) 1978-02-04
IE45646L (en) 1978-02-04
YU188277A (en) 1983-01-21
DK152366C (da) 1988-07-25
NL7708616A (nl) 1978-02-07
PT66865B (fr) 1978-12-29
BG36496A3 (en) 1984-11-15
NO152133C (no) 1985-08-07
JPS6259090B2 (de) 1987-12-09
RO72963A (ro) 1981-11-24
PH18629A (en) 1985-08-23
IE45646B1 (en) 1982-10-20
FI63938C (fi) 1983-09-12

Similar Documents

Publication Publication Date Title
EP2142541B1 (de) Heterotricyclische verbindungen als serotonerge und/oder dopaminerge mittel und anwendungen davon
CA2820362C (en) Substituted pyrazolopyrimidines as glucocerebrosidase activators
CA2595607C (en) Substituted arylamine compounds and their use as 5-ht6 modulators
US4186135A (en) Substituted 2,3-alkylene bis (oxy) benzamides and derivatives and method of preparation
US3769286A (en) Trialkoxy quinazolines
CA2633243C (en) Azepinoindole derivatives as pharmaceutical agents
EP1129093B1 (de) Pyrazolopyimidinon-derivate zur behandlung von impotenz
EP2896624A1 (de) Heterotricyclische Verbindungen als Serotonerge und/oder Dopaminerge Mittel und Anwendungen davon
JP5189595B2 (ja) 新規なジチオロピロロンおよびそれらの治療的応用
DK170702B1 (da) Spiro-isoquinolin-pyrrolidin-tetroner eller farmaceutisk acceptable salte deraf, fremgangsmåde til fremstilling af en del af dem og farmaceutisk præparat omfattende dem
SK12332002A3 (sk) Deriváty chinolínu ako alfa 2 antagonisty
AU2006334820B2 (en) Diazepinones
US3845060A (en) 1-(1-(2,3-dihydro-2-benzofuryl)-alkyl)-4-aminohexahydroisonicotinic acid amides or nitriles
CS216246B2 (en) Method of making the substituted 2,3-alkylen-bis-+l oxy+pbenzamides
US3470168A (en) 2-substituted-4h-1,3-benzothiazin-4-one derivatives
TW202102502A (zh) 作為流感病毒複製抑制劑之稠合多環吡啶酮化合物
US4268512A (en) Substituted 2,3-alkylene bis (oxy) benzamides and derivatives and method of preparation
GB1571447A (en) Substituted 2,3-alkyleneduoxybenzamides
CS219885B2 (en) Method of making the n-lallyl-2-pyrolidylmethyl/-2,3-dimethoxy-5-sulphamoylbenzamide
US4323503A (en) Substituted 2,3-alkylene di (oxy) benzamides and derivatives
KR800001149B1 (ko) 2,3-알킬렌 비스(옥시)벤즈아미드류의 제법
US3586675A (en) Fused thiazines
US4255580A (en) Substituted 2,3-alkylene bis (oxy) benzamides and derivatives
JPH01233284A (ja) 新規縮合ジアゼピノン類、その製法及びこれらの化合物を含む医薬組成物
US3462434A (en) 2-isopropyl-3-(p-amino-phenyl)-3h-4-quinazolone